Reference
Constatin EM, et al. Idarucizumab for reversing anticoagulation in patients treated with dabigatran: Experience in our center. Blood 130 (Suppl. 1): Dec 2017. Available from: URL: http://www.bloodjournal.org/content/130/Suppl_1/4923 [abstract] - Spain
Rights and permissions
About this article
Cite this article
Dabigatran etexilate. Reactions Weekly 1695, 132 (2018). https://doi.org/10.1007/s40278-018-43959-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43959-x